Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Oragenics Inc OGEN

Healthcare Biotechnology
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002 for the treatment of mild traumatic brain injury, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSEAM:OGEN)

Oragenics Q3 2025 Shareholder Update

Business Wire November 12, 2025

Oragenics Regains Full NYSE American Compliance, Company Resolves Stockholder Equity Deficiency

Business Wire October 21, 2025

Oragenics Announces Strategic Partnership with Receptor.AI to Accelerate Pipeline Development

Business Wire October 7, 2025

Oragenics Q2 2025 Shareholder Update

GlobeNewswire August 11, 2025

Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase IIa Trial

GlobeNewswire July 31, 2025

Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development

GlobeNewswire July 16, 2025

Oragenics Completes Approximately $16.5 Million Offering

GlobeNewswire July 2, 2025

Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants

GlobeNewswire July 1, 2025

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium

GlobeNewswire June 10, 2025
View More News ››

Opinion & Analysis (NYSEAM:OGEN)

Speculative stock picks for a scary market environment

J.W. Cotton January 29, 2010
View More Opinion ››

Bullboard Posts (NYSEAM:OGEN)

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - July 1, 2025

Oragenics, Inc. (OGEN): Intranasal Drug Delivery Platform Of

http://beyondspx.com/2024/08/03/oragenics-inc-ogen-intranasal-drug-delivery-platform-offers-promising-concussion-treatment/
MikeTester - August 3, 2024

FSD Pharma Inc is about to launch this breakthrough product

Kevin Harrington Speaks about FSD Pharma<< View Post To Watch Video >>
Peng26 - April 13, 2023

fk it mask off

thinking of the future i bought back into this one for my vaccine play, & purchased OPTI for my non vaccine play
Gonzoboardz - July 21, 2020

RE:Just bought some shares this morning

Sold all. I'll maybe buy back at $1.15
Gonzoboardz - July 14, 2020

Just bought some shares this morning

Just read about the termination of some studies to continue the development of the terraCov2 vaccine 
Gonzoboardz - July 10, 2020
View more Bullboard ››

Viridian Metals Inc.

Viridian Metals Inc.

Viridian Metals Inc. is a Canadian company engaged in generative exploration for critical metals, with a primary focus on ...
View More »